Abstract
Introduction thiourea, 4% CHAPS, 100 mM DTT, 0.2% Biolytes (pH 5-8), 0.01% Bromophenol Blue).
126
For 2D gel electrophoresis, fifty micrograms of proteins in a total of 185 µL of the 127 rehydration buffer were applied to 11 cm Bio-Rad ReadyStrip IPG Strips (pH 5-8) for 128 overnight rehydration. First-dimension isoelectric focusing was performed on a Biorad directly spotted onto MALDI plates. The peptides were analyzed on a 4800 Proteomics
159
Analyzer MALDI-TOF-TOF tandem mass spectrometer (ABI) in a data-dependent 160 fashion using job wide interpretation. MS spectra (m/z 800-3,600) were acquired in 161 positive ion refelectron mode with internal mass calibration. A maximum of up to fifteen 162 of the most intense ions (S/N >50) per spot were selected for subsequent MS/MS 163 analysis in 2.0 keV mode. Each spectrum was averaged over 2,000 laser shots.
(vi) Protein database search and bioinformatics

165
TS2Mascot (Matrix Science Inc., Boston, MA, USA) was used to generate peak list as if they could be established at greater than 95% probability as specified by the Peptide
178
Prophet algorithm (21). Protein identifications were accepted if they could be 179 established at greater than 95% probability and contained at least 2 identified peptides 180 with a false discovery rate of ≤0.1%. Protein probabilities were assigned by the Protein Prophet algorithm (28). Proteins that contained similar peptides and could not be 182 differentiated based on MS/MS analysis alone were grouped to satisfy the principles of 183 parsimony. Peptides were quantitated using the centroided reporter ion peak intensity.
184
Intra-sample channels were normalized based on the median ratio for were selected because they would be most likely to contribute to potential sera-based 262 biomarkers.
263
In the susceptible strain a total of 471 proteins were identified from these fractions 264 However, using the strict criteria of 2 peptides with 95% confidence and protein 265 identification probability of 95%, 261 proteins were used for the final analysis (Table 1   266 and supplementary Table S1 ). In the presence of drug (0.12 µg/ml caspofungin), 
